Two and a half years into his tenure as Emergent BioSolutions CEO, Joseph Papa is executing another round of restructuring to ...

Galderma Laboratories has landed a blow on Sanofi in its multi-case advertising row, driving the French drugmaker to change ...

Fujifilm Biotechnologies passed the leadership reins to Maja Pedersen, adding president to her current role as COO while former Chief Executive Lars Petersen transitions to a strategic advisor ...

HIV drugmaker ViiV Healthcare is helping prospective HIV prevention or treatment users to make a choice that will help them later down the line in its “Do It For Future You” campaign. The multichannel ...

Despite a major curveball thrown by the FDA earlier this year, Moderna has managed to strike true with a U.S. approval for its mRNA-based influenza vaccine.  | Despite a major curveball thrown by the ...

News of the unconfirmed deal talks drew major investor pushback on AZ’s side, with the British drugmaker’s stock sliding nearly 9% following the Financial Times report. The company’s London-listed ...

AstraZeneca and CSPC Pharmaceutical are strengthening their partnership by establishing a new biologics manufacturing joint ...

Novo’s Wegovy pill thesis continues to bear out in 2026, as the oral obesity med keeps impressive sales apace while sparing ...

Gilead Sciences’ HIV prevention business reached a milestone, exceeding $1 billion in quarterly sales for the first time. | ...

On Tuesday, Novo reported its quarterly results which showed that Wegovy pill generated sales of 3.22 billion Danish kroner ...

It’s been years since Big Pharma last witnessed a megamerger. In the late 2010s, Takeda bought Shire, AbbVie acquired ...

With the help of emerging internet communities on social media spaces such as Reddit, women are discovering new ways to ...